Professional Documents
Culture Documents
Posterior Capsule Opacification: Comparison of 3 Intraocular Lenses of Different Materials and Design
Posterior Capsule Opacification: Comparison of 3 Intraocular Lenses of Different Materials and Design
edge on the IOL surface are important in the prevention of PCO.4 6 Intraocular-lens-related factors such
as IOL material biocompatibility and design are major
determinants.7,8
In this study, we focused on IOL-related factors
and performed a prospective study with a 2-year
follow-up of 3 IOL types after modern, standardized
phacoemulsification.
HSM PMMA
809C
Silicone
SI-40NB
AcrySof
MA60BM
Number
61
60
59
Median
74
73
75
Range
6283
6284
6186
Male
20
32
21
Female
41
28
38
Age (y)
Sex
degeneration were accepted. Patients on preoperative oral steroid therapy or with diabetes mellitus were not included.
The patients were randomized to have implantation of 1
of 3 types of IOLs: single-piece heparin-surface-modified
(HSM) poly(methyl methacrylate) (PMMA) (809C, Pharmacia & Upjohn) with an optic diameter of 5.0 mm (n 61),
foldable 3-piece silicone (SI-40NB, Allergan) with an optic
diameter of 6.0 mm (n 60), or 3-piece foldable acrylic
(AcrySof MA60BM, Alcon) with an optic diameter of
6.0 mm (n 59) (Table 1). The MA60BM has a sharp-edged
optic, and the 809C and SI-40NB have round-edged optics.
Preoperatively, the pupil was dilated with a combination
of topical cyclopentolate 0.75% and phenylephrine 2.5%.
Cataract surgery was performed by the same surgeon (C.Z.)
using a standardized procedure. Anesthesia comprised topical
tetracaine chloride 0.5% and a subconjunctival injection of
lidocaine hydrochloride 1% (Xylocaine) and adrenaline
0.05%.
The surgery was performed through a 3.2 mm corneoscleral incision. Sodium hyaluronate 1% (Healon) was used
as a viscoelastic material. A CCC approximately 4.5 to
5.5 mm was created. Hydrodissection and hydrodelineation
were performed using balanced salt solution (BSS). Phacoemulsification was in the capsular bag using the divide-andconquer technique. Cortical lens material was aspirated
with an irrigation/aspiration tip using BSS with adrenaline
0.3 mg/500 mL for intraocular infusion. An IOL was implanted in the bag, and the incision was widened to 5.0 mm
for the HSM PMMA IOLs and to 3.4 to 3.6 mm for foldable
silicone or AcrySof IOLs. No-stitch wound closure was used
in all cases. Postoperatively, topical dexamethasone 0.1% was
prescribed 3 times a day for 1 week and 2 times a day for 2
weeks.
To evaluate PCO, a retroillumination photograph was
taken through a dilated pupil using a slitlamp and photographic setup. The images were digitized and imported into
the Evaluation of Posterior Capsule Opacification (EPCO)
computer-analysis system developed by Tetz et al.9 With
EPCO, the PCO density is interactively scored on a scale from
Results
At 2 years, 17 of the 180 patients were lost to followup. Thirty patients were excluded from individual analysis because the images were of poor quality. After Nd:
YAG capsulotomy, patients were excluded from further
image analysis. Images from those patients were given
the highest rank in the statistical analysis.
The image analyses showed that the HSM PMMA
IOL group had significantly more PCO than the silicone and AcrySof IOL groups; the silicone group had
significantly more PCO than the AcrySof group
(P.05) (Table 2). After a 2-year follow-up, the Nd:
YAG capsulotomy rate was 20% (n 10) in the HSM
PMMA group, 22% (n 10) in the silicone group, and
8% (n 3) in the AcrySof group. The difference in the
Nd:YAG rate was not statistically significant among the
groups (P.05) (Table 2).
Ninety-five percent of all patients had a best corrected visual acuity (BCVA) of 20/40 or better at 2 years
(Table 3). Patients who had an Nd:YAG capsulotomy
before 2 years postoperatively were not included in the
Table 2. Average ranks of individual EPCO scores and Nd:YAG
frequency by IOL type.
IOL Group
HSM PMMA
809C
Parameter
Number of patients
Average of ranks*
Silicone AcrySof
SI-40NB MA60BM
49
46
38
87
67
43
20
22
1557
IOL
BCVA
(Range)
20/40
Silicone* (n 40)
AcrySof (n 36)
Number
of
Patients EPCO Score
(%)
(Median)
3 (7)
0.741
20/4020/25
8 (19)
0.456
20/25
32 (74)
0.649
20/40
2 (5)
1.807
20/4020/25
8 (20)
0.167
20/25
30 (75)
0.145
20/40
1 (3)
0.411
20/4020/25
6 (17)
0.200
20/25
29 (80)
0.020
Discussion
This prospective study shows that there are differences in PCO formation depending on which IOL is
used. There was significantly less PCO 2 years postoperatively in eyes with an AcrySof IOL. These results
agree with those in previous studies.10 12 The BCVA
was good in most patients at the 2-year follow-up. When
patients notice impaired visual function, they often
want to be treated as soon as possible. Therefore, the
Nd:YAG capsulotomy treatments in our study were
spread over time and not performed when patients came
for a regular examination. The patients who had an
Nd:YAG capsulotomy before 2 years were excluded
from the BCVA analysis at 2 years because we could not
obtain EPCO scores from them to evaluate PCO. However, the higher median EPCO scores in patients with
1558
1995, the AcrySof was the only IOL with a sharp edge
that was commercially available to us.
In conclusion, this study demonstrates that patients
with an AcrySof IOL developed significantly less PCO
than those with a silicone or HSM PMMA IOL with a
round-edged design. The AcrySof IOL also leads to a
lower Nd:YAG capsulotomy rate. With modern IOLs,
PCO formation is reduced; however, the duration of the
IOL in the eye plays an important role. Therefore, longterm studies are required to understand how various
IOLs perform in relation to PCO.
References
1. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol 1992; 37:73116
2. Schaumberg DA, Dana MR, Christen WG, Glynn RJ. A
systematic overview of the incidence of posterior capsule
opacification. Ophthalmology 1998; 105:12131221
3. Schmidbauer JM, Vargas LG, Peng Q, et al. Posterior
capsule opacification. Int Ophthalmol Clin 2001; 41(3):
109 131
4. Peng Q, Apple DJ, Visessook N, et al. Surgical prevention of posterior capsule opacification. Part 2: enhancement of cortical cleanup by focusing on hydrodissection.
J Cataract Refract Surg 2000; 26:188 197
5. Ram J, Apple DJ, Peng Q, et al. Update on fixation of
rigid and foldable posterior chamber intraocular lenses.
Part II: choosing the correct haptic fixation and intraocular lens design to help eradicate posterior capsule opacification. Ophthalmology 1999; 106:891900
6. Ravalico G, Tognetto D, Palomba M, et al. Capsulorhexis size and posterior capsule opacification. J Cataract
Refract Surg 1996; 22:98 103
7. Hollick EJ, Spalton DJ, Ursell PG, Pande MV. Biocompatibility of poly(methyl methacrylate), silicone, and
AcrySof intraocular lenses: randomized comparison of
the cellular reaction on the anterior lens surface. J Cataract Refract Surg 1998; 24:361366
8. Peng Q, Visessook N, Apple DJ, et al. Surgical prevention of posterior capsule opacification. Part 3: intraocular
lens optic barrier effect as a second line of defense. J Cataract Refract Surg 2000; 26:198 213
9. Tetz MR, Auffarth GU, Sperker M, et al. Photographic
image analysis system of posterior capsule opacification.
J Cataract Refract Surg 1997; 23:15151520
10. Ursell PG, Spalton DJ, Pande MV, et al. Relationship
between intraocular lens biomaterials and posterior capsule opacification. J Cataract Refract Surg 1998; 24:352
360
11. Hollick EJ, Spalton DJ, Ursell PG, et al. The effect of
polymethylmethacrylate, silicone, and polyacrylic intraocular lenses on posterior capsular opacification 3
years after cataract surgery. Ophthalmology 1999; 106:
49 54; discussion by RC Drews, 54 55
12. Ram J, Kaushik S, Brar GS, Gupta A. Neodymium: YAG
capsulotomy rates following phacoemulsification with
implantation of PMMA, silicone, and acrylic intraocular
lenses. Ophthalmic Surg Lasers 2001; 32:375382
13. Hayashi H, Hayashi K, Nakao F, Hayashi F. Quantitative comparison of posterior capsule opacification after
polymethylmethacrylate, silicone, and soft acrylic intraocular lens implantation. Arch Ophthalmol 1998;
116:1579 1582
14. Oshika T, Nagata T, Ishii Y. Adhesion of lens capsule to
intraocular lenses of polymethylmethacrylate, silicone,
and acrylic foldable materials: an experimental study. Br J
Ophthalmol 1998; 82:549 553
15. Nagata T, Minakata A, Watanabe I. Adhesiveness of
AcrySof to a collagen film. J Cataract Refract Surg 1998;
24:367370
16. Nishi O, Nishi K, Sakanishi K. Inhibition of migrating
lens epithelial cells at the capsular bend created by the
rectangular optic edge of a posterior chamber intraocular
lens. Ophthalmic Surg Lasers 1998; 29:587594
17. Nishi O. Posterior capsule opacification. Part 1: experimental investigations. J Cataract Refract Surg 1999; 25:
106 117
18. Nishi O, Nishi K. Preventing posterior capsule opacification by creating a discontinuous sharp bend in the capsule. J Cataract Refract Surg 1999; 25:521526
19. Nishi O, Nishi K, Wickstro m K. Preventing lens epithelial cell migration using intraocular lenses with sharp rectangular edges. J Cataract Refract Surg 2000; 26:1543
1549
20. Nishi O, Nishi K, Akura J, Nagata T. Effect of roundedged acrylic intraocular lenses on preventing posterior
capsule opacification. J Cataract Refract Surg 2001; 27:
608 613
21. Kruger AJ, Schauersberger J, Abela C, et al. Two year
results: sharp versus rounded optic edges on silicone
lenses. J Cataract Refract Surg 2000; 26:566 570
From St. Eriks Eye Hospital, Stockholm, Sweden.
Presented at the ASCRS Symposium on Cataract, IOL and Refractive
Surgery, San Diego, California, USA, April 2001, and the XIXth Congress of the European Society of Cataract & Refractive Surgeons, Amsterdam, The Netherlands, September 2001.
None of the authors has a proprietary or financial interest in any material, method, or product mentioned.
1559